Cambridge Investment Research Advisors, Inc. Veru Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Veru Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 27,850 shares of VERU stock, worth $83,828. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,850
Previous 1,423,288
98.04%
Holding current value
$83,828
Previous $698,000
97.71%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VERU
# of Institutions
114Shares Held
43.1MCall Options Held
50.5KPut Options Held
824K-
Black Rock Inc. New York, NY7.65MShares$23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.41MShares$19.3 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.91MShares$14.8 Million0.56% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.62MShares$7.89 Million0.0% of portfolio
-
Ubs Group Ag1.65MShares$4.98 Million0.0% of portfolio
About VERU INC.
- Ticker VERU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,146,704
- Market Cap $241M
- Description
- Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....